OOIR: Observatory of International Research

Papers

(The H4-Index of JNCI-Journal of the National Cancer Institute is 40. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Correction to: ATM Germline-Mutated Gastroesophageal Junction Adenocarcinomas: Clinical Descriptors, Molecular Characteristics, and Potential Therapeutic Implications	254
Vertical integration in oncology: what does it mean for patients with cancer?	179
Re: Deng and Heybati	173
Pre- and post-diagnostic use of antihypertensive medications and stage I-III colorectal cancer survival: prospective cohort study	145
Response to Liu and Zhang	123
Addressing Diversity, Equity, and Inclusion at the JNCI Journals	107
Factors associated with timely COVID-19 vaccination in a population-based cohort of patients with cancer	92
The National Cancer Institute Funding of Global Research: Lessons Learned and Opportunities Going Forward	83
RE: Use of artificial intelligence for cancer clinical trial enrollment	79
RE: Exploring the cross-cancer effect of circulating proteins and discovering potential intervention targets for 13 site-specific cancers	74
Mediators of Racial Disparities in Heart Dose Among Whole Breast Radiotherapy Patients	64
Dyslipidemia and cardiovascular disease among childhood cancer survivors: a St. Jude Lifetime Cohort report	63
Metabolically (un)healthy obesity and risk of obesity-related cancers: a pooled study	63
Method of primary breast cancer detection and the disease-free interval, adjusting for lead time	62
Ethylene oxide emissions and incident breast cancer and non-Hodgkin lymphoma in a US cohort	61
Race and clinical outcomes in hormone receptor-positive, HER2-negative, node-positive breast cancer in the randomized RxPONDER trial	60
Discovering plasma proteins associated with breast cancer incidence in postmenopausal women in the Atherosclerosis Risk in Communities study	59
Survivorship after adolescent and young adult cancer: models of care, disparities, and opportunities	58
The Unrelenting Impact of Poverty on Cancer: Structural Inequities Call for Research and Solutions on Structural Determinants	58
Long-term aspirin use and cancer risk: a 20-year cohort study	55
Reduced adipose tissue with limited loss of lean mass after weight loss: results from the Prostate Cancer Active Lifestyle Study	53
Evaluating a blood test for colon cancer screening: how simulation modeling can inform clinical policy making and research	53
Incorporation of patient-reported outcomes in pediatric cancer clinical trials: design, implementation, and dissemination	53
The National Cancer Institute clinical trials planning meeting to address gaps in observational and intervention trials for cancer-related cognitive impairment	52
Medication–Associated Phthalate Exposure and Childhood Cancer Incidence	51

Increasing diversity in clinical trials: demographic trends at the National Cancer Institute, 2005-2020	51
Independent associations between obesity, glucose metabolism, and breast cancer risk through unrelated pathways	47
Understanding risk factors for endometrial cancer in young women	47
Systematic investigation of genetically determined plasma and urinary metabolites to discover potential interventional targets for colorectal cancer	47
Premature aging as an accumulation of deficits in young adult survivors of pediatric cancer	46
Response to Omoleye, Esserman, Olufunmilayo	45
Evaluating colonoscopy quality by performing provider type	45
Determinants of late metastases in renal cell carcinoma	45
RE: Prevalence of cancer survivors in the United States	45
Correction to: Obesity-Specific Improvement of Lung Cancer Outcomes and Immunotherapy Efficacy with Metformin	44
The National Health Service-Galleri multi-cancer screening trial: explanation and justification of unique and important design issues	44
Correction to: Quality of Life in Older Adults After Major Cancer Surgery: The GOSAFE International Study	43
Stat Bite: Prevalence of cancer in the United States in 2022	43
Association between racialized economic segregation and stage at diagnosis for 3 screenable cancers in New York City	41
Urgent need to mitigate disparities in federal funding for cancer research	40
The triple effect of colorectal cancer screening: reducing deaths, government spending, and mortality disparities	40